Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. With the cluttered landscape of both lab-based and lateral flow serology testing options, it has become challenging to know which way to lean, and where the cross section of accuracy and access lie.
In this webinar, Dr. Jerry Yeo, Professor and Medical Director of Clinical Chemistry at University of Chicago, and Dr. Stephen Rawlings, Infectious Disease Fellow at University of California, San Diego, will summarize their thoughts on the value, utility and limitations of antibody tests for SARS-CoV-2.
They will review how rapid lateral flow serology tests work and considerations when choosing a test. They will also share data from their independent studies focused on assessing the performance of lateral flow tests, including a comparison to a standard laboratory serology instrument.